Objective:
To compare the effectiveness of two intra-articular platelet-rich plasma (PRP) injections with a single corticosteroid injection and oral nonsteroidal anti-inflammatory drug (NSAID) therapy in patients with advanced knee osteoarthritis awaiting knee replacement.
Approach:
- PRP group showed significant reductions in pain scores from about 6 at baseline to about 3 at 3 months (p < 0.001) and about 4 at 6 months (p < 0.01).
- WOMAC total scores improved significantly in the PRP group from 49 at baseline to 28 at 3 months (p < 0.001) and 33 at 6 months (p < 0.01).
- Rescue opioid use was lower in the PRP group at 3 months compared to both comparator groups (p < 0.05).
- Biomarker analysis indicated lower levels of several inflammatory markers in the PRP group compared to corticosteroid and NSAID groups (p < 0.05).
- No placebo or sham-injection group was included, limiting the ability to assess the efficacy of PRP against an inert control.
- The study design and open-label conditions may introduce bias.
- The small sample size and short follow-up period limit generalizability.
Key Findings:
Interpretation:
The findings suggest that PRP may provide better pain relief and functional improvement compared to corticosteroid injections and NSAID therapy in patients with advanced knee osteoarthritis.
Limitations:
Conclusion:
Further research with larger, longer-duration randomized trials is needed to confirm these findings and address the limitations of the current study.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
